abstract |
The present invention relates to a composition for a P2X 7 receptor activity inhibition, including a variety of novel hydrazine derivatives thereof and the active ingredient. The present invention can be usefully used for the prevention or treatment of various diseases related to the activity of P2X 7 receptor, i.e., chronic inflammatory diseases, inflammatory pain, neuropathic pain, autoimmune diseases or degenerative diseases. |